Skip Nav Destination
Issues
Potential Z-DNA-forming elements in serum DNA from human systemic lupus erythematosus.
J Immunol (1985) 134 (1): 177–179.
Immunoglobulin subclass (IgG3) restriction of anti-P and anti-Pk antibodies in patients of the rare p blood group.
J Immunol (1985) 134 (1): 1–3.
H-2K-restricted granuloma formation by Ly-2+ T cells in antibacterial protection to facultative intracellular bacteria.
J Immunol (1985) 134 (1): 569–572.
Demonstration of structural polymorphism among MB3 light chains by two-dimensional gel electrophoresis.
N Ishikawa; M Kasahara; H Ikeda; K Ogasawara; S Hawkin; T Takenouchi; A Wakisaka; Y Kikuchi; M Aizawa
J Immunol (1985) 134 (1): 417–422.
Strain dependence of muramyl dipeptide-induced LAF(IL 1) release by murine-adherent peritoneal cells.
J Immunol (1985) 134 (1): 365–368.
Reconstitution of nude mouse T cell function in vivo: IL 2-independent effect of human T cells.
J Immunol (1985) 134 (1): 336–342.
Characterization of a polyvalent antibody directed against the IgG Fc receptor of human mononuclear phagocytes.
J Immunol (1985) 134 (1): 465–470.
Comparison of MHC genes among distantly related members of the genus Mus.
J Immunol (1985) 134 (1): 630–636.
Morphologic and immunologic characterization of human basophils developed in cultures of cord blood mononuclear cells.
J Immunol (1985) 134 (1): 532–540.
Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages.
J Immunol (1985) 134 (1): 138–144.
Effects of short-term administration of sex hormones on normal and autoimmune mice.
J Immunol (1985) 134 (1): 204–210.
A novel IgA protease from Clostridium sp. capable of cleaving IgA1 and IgA2 A2m(1) but not IgA2 A2m(2) allotype paraproteins.
J Immunol (1985) 134 (1): 573–576.
Circadian and/or circahemidian rhythms in nine lymphocyte-related variables from peripheral blood of healthy subjects.
J Immunol (1985) 134 (1): 217–222.
B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations.
J Immunol (1985) 134 (1): 603–607.
T15 D region germ line amino acid sequences distinguished by monoclonal anti-idiotope antibody.
J Immunol (1985) 134 (1): 436–442.
Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles.
J Immunol (1985) 134 (1): 145–150.
Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome.
J Immunol (1985) 134 (1): 151–156.
Characterization of the effects of phorbol esters on rat mast cell secretion.
J Immunol (1985) 134 (1): 548–555.
Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1.
J Immunol (1985) 134 (1): 343–349.
The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
J Immunol (1985) 134 (1): 495–499.
Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
J Immunol (1985) 134 (1): 492–494.
A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides.
J Immunol (1985) 134 (1): 471–477.
Purification and physicochemical characterization of murine T cell replacing factor (TRF).
J Immunol (1985) 134 (1): 382–389.
Suppression of in vitro CML generation by alloactivated lymphocytes: analysis of antigen-nonspecific suppressive mechanisms.
J Immunol (1985) 134 (1): 45–50.
Suppressor T lymphocyte induction by a factor released from cultured blastocysts.
J Immunol (1985) 134 (1): 404–409.
Antiprotozoan activity of nonspecific cytotoxic cells (NCC) from the channel catfish (Ictalurus punctatus).
J Immunol (1985) 134 (1): 78–85.
Differences in T15 expression of primary and secondary anti-PC responses with T cells from T15+ and T15- donors.
J Immunol (1985) 134 (1): 23–28.
Identification of an antigen specific to Trypanosoma congolense by using monoclonal antibodies.
J Immunol (1985) 134 (1): 593–597.
Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.
J Immunol (1985) 134 (1): 410–416.
Splenic B cells from CBA/N mice acquire responsiveness to anti-immunoglobulin after a brief treatment with pronase.
J Immunol (1985) 134 (1): 4–6.
Suppression of human NK cell cytotoxicity by an MLC-Generated cell population.
J Immunol (1985) 134 (1): 272–279.
Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E.
J Immunol (1985) 134 (1): 172–176.
Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
J Immunol (1985) 134 (1): 512–517.
The murine plasma cell antigen PC-1: purification and partial amino acid sequence.
J Immunol (1985) 134 (1): 443–448.
Cytofluorometric isolation of I937, an Ia antigen-bearing variant of the Ia-negative human monocytic cell line U937.
J Immunol (1985) 134 (1): 280–283.
Subsets of Lyt-2+ cells defined by differential expression of the 9F3 antigen: alterations in mice of the lpr/lpr genotype.
J Immunol (1985) 134 (1): 196–203.
Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
J Immunol (1985) 134 (1): 375–381.
Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells.
J Immunol (1985) 134 (1): 37–44.
Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2).
J Immunol (1985) 134 (1): 577–584.
Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
J Immunol (1985) 134 (1): 211–216.
Transcriptional regulation of HLA class II and invariant chain genes.
J Immunol (1985) 134 (1): 637–640.
In vitro mutagenesis of a mouse MHC class I gene for the examination of structure-function relationships.
J Immunol (1985) 134 (1): 623–629.
Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo.
J Immunol (1985) 134 (1): 564–568.
T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
J Immunol (1985) 134 (1): 369–374.
Effect of wheat germ agglutinin on the interleukin pathway of human T lymphocyte activation.
J Immunol (1985) 134 (1): 314–323.
T cells with FC receptors in myeloma; suppression of growth and secretion of MOPC-315 by T alpha cells.
J Immunol (1985) 134 (1): 644–647.
Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes.
J Immunol (1985) 134 (1): 230–234.
Stimulation of in vitro immunoglobulin production by interferon-alpha.
J Immunol (1985) 134 (1): 299–304.
The human thymic microenvironment. Phenotypic characterization of Hassall's bodies with the use of monoclonal antibodies.
J Immunol (1985) 134 (1): 250–257.
Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2.
J Immunol (1985) 134 (1): 324–329.
Human alloreactive CTL clones: loss and reacquisition of specific cytolytic activity can be regulated by "recombinant" interleukin 2.
J Immunol (1985) 134 (1): 310–313.
Purification and distribution of a novel macrophage-specific calmodulin-binding glycoprotein.
J Immunol (1985) 134 (1): 449–456.
MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
J Immunol (1985) 134 (1): 305–309.
Differential glycosylation requirements for the cell surface expression of class I molecules.
J Immunol (1985) 134 (1): 423–430.
In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.
J Immunol (1985) 134 (1): 157–166.
Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
J Immunol (1985) 134 (1): 258–264.
Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice.
J Immunol (1985) 134 (1): 598–602.
Defective IFN-gamma production in the human neonate. I. Dysregulation rather than intrinsic abnormality.
J Immunol (1985) 134 (1): 167–171.
Natural killer cell-mediated cytotoxicity does not depend on recognition of mannose 6-phosphate residues.
J Immunol (1985) 134 (1): 65–69.
Localization of the human MHC-linked complement genes between HLA-B and HLA-DR by using HLA mutant cell lines.
J Immunol (1985) 134 (1): 641–643.
Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
J Immunol (1985) 134 (1): 500–505.
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement
Advertisement